United States · 
Who invested in Mediar Therapeutics?
Mediar Therapeutics's investors include Sofinnova Partners, Mission BioCapital, Novartis and Longwood Fund.
2023202420252026
$85MSeries A$76MSeries B
United States · Series B startup
Who invested in Mediar Therapeutics
Funding summaryUpdated 26 Oct 2026
$161Mraised across 2 rounds since 2023, from 2 sources
$85MSeries A$76MSeries B
- Latest round
- Series B, $76MJan 2026
- Biggest round
- $85MSeries A · Mar 2023
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $85M Mar 2023
- Biggest round
- $85M Series A · Mar 2023
- Between rounds
- 2.8 years from the last two
The rounds
- Jan 2026Series B$76M1 new2 returning
Source recordedSEC filing: $38M sold, first sale Dec 2025
- Mar 2023Series A$85M3 new
Source recordedSEC filing: $32M sold, first sale Nov 2022
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Mediar Therapeutics
How much has Mediar Therapeutics raised?
Mediar Therapeutics has raised $161M across 2 rounds since 2023.
When did Mediar Therapeutics last raise?
Mediar Therapeutics's most recent round was a Series B of $76M in Jan 2026.
What was Mediar Therapeutics's biggest round?
Mediar Therapeutics's largest round on record is $85M (Series A), in Mar 2023.
Who backed Mediar Therapeutics first?
Mediar Therapeutics's first round on record, in Mar 2023, was backed by Sofinnova Partners, Novartis and Mission BioCapital.
What stage is Mediar Therapeutics at?
Mediar Therapeutics's latest named round is a Series B, in Jan 2026.
Where is Mediar Therapeutics based?
Mediar Therapeutics is based in the United States.
Companies like Mediar Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.